Idiopathic hypereosinophilic syndrome

Search Trials
Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
Status:
Completed
Last Changed:
May 6, 2019
First Changed:
Nov 18, 2005
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
Dasatinib (BMS-354825)
Eosinophilia Diagnosis
Status:
Unknown status
Last Changed:
Jun 5, 2019
First Changed:
Oct 21, 2015
Disease(s):
Hypereosinophilic Syndrome
Intervention(s):
Scheduled exams and diagnosis
Steroid Treatment for Hypereosinophilic Syndrome
Status:
Completed
Last Changed:
Feb 15, 2022
First Changed:
Feb 2, 2012
Disease(s):
Eosinophilia
Intervention(s):
prednisone
Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias
Status:
Unknown status
Last Changed:
Sep 15, 2009
First Changed:
Jan 13, 2006
Disease(s):
Hypereosinophilic Syndrome
Intervention(s):
STI571
Phase II Gleevec Idiopathic Hypereosinophilic Syndrome
Status:
Terminated
Last Changed:
May 10, 2021
First Changed:
Sep 30, 2005
Disease(s):
Eosinophilia
Intervention(s):
Gleevec

Connect. Empower. Inspire.